#EBW25 Previews: State-of-the-art speaker for 4C ‘Implementing and securing quality control in biobanking’
Dr. Ronny Baber from University Leipzig will be the state-of-the-art speaker leading the panel session: ‘Implementing and securing quality control in biobanking’. We have profiled his biography and abstract here.
Dr. Ronny Baber
Dr. Ronny Baber works in the Institute of Laboratory Medicine, Clinical Chemistry, and Molecular Diagnostics at the University Hospital Leipzig. He is the head of the Leipzig Medical Biobank and the LIFE-Preanalytical laboratory in the Leipzig Research Center for Civilisation Diseases (LIFE).
Dr. Baber is a member of the working group in the German Institute for Standardization (DIN), which supports the ISO TC 276 responsible for the ISO standard 20387 on biobanking, and BBMRI-ERIC working groups for the evaluation of CEN standards. He is also part of the Steering Committee and different working groups in the German Biobank Alliance (GBA).
Since September 2017 he has been part of the ESBB Executive Board. He has also been a member of the Ethics Committee at Leipzig University’s Faculty of Medicine since 2020.
Abstract: Enhancing biobanking quality: Validation and verification strategies with insights from the Leipzig Medical Biobank
DIN EN ISO 20387, the international standard for biobanking, outlines the requirements for
quality and competence in the management of biological resources, including the validation
and verification of processes and methods. Both are critical to maintaining reproducibility,
with validation assessing whether the specific requirements for the intended use have been
met and verification confirming that the established criteria for the method have been met.
The Leipzig Medical Biobank (LMB) has implemented protocols to improve the quality of
biobanking processes and biobanked samples. Key processes and methods such as sample
viability, DNA/RNA quantity, quality and integrity, and storage conditions were validated or
verified according to DIN EN ISO 20387. As the quality of the samples must be appropriate
for the purpose of the subsequent analytical procedures, various process- and sample related
deficiencies were also addressed. In addition, the LMB carried out proficiency tests,
which are mainly offered by the German Biobank Network and its associated partners.
The LMB demonstrates how its validation and verification strategy improves the quality of
biobanking processes and biobanked samples. It is important to gain knowledge about the
life cycle of biospecimens. In doing so, biobanks can be reliable partners for researchers by
being able to answer unasked questions about factors that affect sample quality.
Session details
- Date: Wednesday 14 May
- Time: 17:30-19:00